• Pharma
  • October 24, 2020
  • 3 views
Bharat biotech’s Covid-19 vaccine Covaxin gets DCGI nod for phase 3 clinical trial

New Delhi: The Drugs Controller General of India (DCGI) on Friday permitted Bharat Biotech to conduct phase 3 clinical trials of its indigenously developed Covid-19 vaccine with certain conditions, officials said. A subject expert committee on Covid-19 at…